| Literature DB >> 6467824 |
A R Manhire, P Dawson, R Dennet.
Abstract
When used in central venous injections for digital subtraction angiography, sodium meglumine ioxaglate (Hexabrix) has been found to be associated with a high incidence of nausea and vomiting (24.5%), when compared with iohexol (Omnipaque) (0%) in 101 patients. A mechanism is suggested to account for this observation based on the anticholinesterase activity of ioxaglate.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6467824 DOI: 10.1016/s0009-9260(84)80186-5
Source DB: PubMed Journal: Clin Radiol ISSN: 0009-9260 Impact factor: 2.350